![Mark Versavel](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Mark Versavel is the founder of Vzenium LLC.
He previously worked as the Chief Medical Officer at Cavion, Inc., Alzheon, Inc., and NeuroBo Pharmaceuticals, Inc. In 2023, he held the position of Chief Medical Officer at Eliem Therapeutics, Inc. Dr. Versavel obtained an MBA from the University of Michigan in 2003.
He also earned a doctorate degree from Humboldt-Universität zu Berlin in 2003 and another doctorate degree from the University of Antwerp in 1983.
Postes actifs de Mark Versavel
| Sociétés | Poste | Début |
|---|---|---|
Vzenium LLC | Fondateur | - |
Anciens postes connus de Mark Versavel
| Sociétés | Poste | Fin |
|---|---|---|
| CLIMB BIO, INC. | Directeur Technique/Scientifique/R&D | 01/10/2023 |
Cavion, Inc.
 Cavion, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes oncology drugs for solid tumors | Directeur Technique/Scientifique/R&D | - |
| METAVIA INC. | Directeur Technique/Scientifique/R&D | - |
| ALZHEON, INC. | Directeur Technique/Scientifique/R&D | - |
Formation de Mark Versavel
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
98
Relations au 1er degré
8
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 8 |
|---|---|
Cavion, Inc.
Cavion, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes oncology drugs for solid tumors | Health Technology |
Alzheon, Inc.
 Alzheon, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company that develops drugs for neurodegenerative disorders | Health Technology |
University of Michigan
 University of Michigan Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Humboldt-Universität zu Berlin
 Humboldt-Universität zu Berlin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Antwerp
 University of Antwerp Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Eliem Therapeutics, Inc.
 Eliem Therapeutics, Inc. BiotechnologyHealth Technology Operates as clinical-stage biotechnology company focused on developing novel therapies for neuronal excitability disorders | Health Technology |
NeuroBo Pharmaceuticals, Inc.
 NeuroBo Pharmaceuticals, Inc. BiotechnologyHealth Technology Researches and develops disease-modifying therapies for neurodegenerative diseases | Health Technology |
Vzenium LLC |
